Merriman Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$283K Sell
366
-604
-62% -$500K 0.01% 174
2024
Q3
$859K Buy
970
+20
+2% +$18K 0.03% 109
2024
Q2
$860K Buy
950
+25
+3% +$20K 0.04% 105
2024
Q1
$719K Buy
+925
New +$658K 0.03% 117

Other funds holding LLY

Merriman Wealth Management's LLY Position: Q4 2024 in Review

Merriman Wealth Management reduced its Eli Lilly (LLY) stake by 62% in Q4 2024, selling an estimated $500K and leaving 366 shares worth $283K. The position accounts for 0.01% of the portfolio, ranked #174.

Merriman Wealth Management first reported a position in LLY in Q1 2024 and has held it in 4 quarters since. The position peaked at $860K in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Merriman Wealth Management held 366 shares of Eli Lilly worth $283K as of Q4 2024.
  • Merriman Wealth Management sold 604 Eli Lilly shares in Q4 2024, an estimated $500K.
  • Eli Lilly made up 0.01% of Merriman Wealth Management's portfolio in Q4 2024, its #174 holding.
  • Merriman Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 4 quarters since.
  • Merriman Wealth Management's Eli Lilly position peaked at $860K in Q2 2024.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Merriman Wealth Management's 13F filing for Q4 2024, filed 13 Feb 2025.